Other KLKs have emerged as key players in PCa pathogenesis, particularly KLK2, KLK4, and KLK14, which are implicated in cancer progression through protease activity, AR modulation, and interaction with extracellular matrix components [7]. This evidence concerns the gene KLK2 and cancer.